Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Leukemia, Myeloid, Chronic, BCR-ABL Positive”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Active Not RecruitingNCT04971226
What this trial is testing

Oral Asciminib Versus Other TKIs in Adult Patients With Newly Diagnosed Ph+ CML-CP

Who this might be right for
Chronic Myeloid Leukemia (CML) Philadelphia Chromosome Positive
Novartis Pharmaceuticals 405
Early research (Phase 1)Ended earlyNCT02381548
What this trial is testing

Phase I Trial of AZD1775 and Belinostat in Treating Patients With Relapsed or Refractory Myeloid Malignancies or Untreated Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid LeukemiaAcute Myeloid Leukemia Post Cytotoxic TherapyBlast Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive+6 more
National Cancer Institute (NCI) 20
Testing effectiveness (Phase 2)Ended earlyNCT00790855
What this trial is testing

Bendamustine in Acute Leukemia and MDS

Who this might be right for
Acute Myeloid LeukemiaMyelodysplastic SyndromeAcute Lymphoblastic Leukemia+1 more
M.D. Anderson Cancer Center 27
Early research (Phase 1)Ended earlyNCT00860535
What this trial is testing

Growth Factor Signature (GFS) Pilot Study (MK0000-098)(COMPLETED)

Who this might be right for
Blast Phase Philadelphia Chromosomes Positive (Ph+) Chronic Myelogenous Leukemia (CML)Philadelphia Chromosome Positive (Ph+) Acute Lymphocytic Leukemia (ALL)
Merck Sharp & Dohme LLC 9
Not applicableLooking for participantsNCT02333604
What this trial is testing

Cancer Experience Registry (CER) for Cancer Patients and Caregivers

Who this might be right for
NeoplasmsCancerCaregiver
Cancer Support Community, Research and Training Institute, Philadelphia 15,000
Testing effectiveness (Phase 2)Study completedNCT00317785
What this trial is testing

Total-Body Irradiation and Cyclophosphamide in Treating Patients Who Are Undergoing Donor Stem Cell Transplant for Hematologic Cancer and Other Diseases

Who this might be right for
LeukemiaLymphomaMyelodysplastic Syndromes
Fred Hutchinson Cancer Center 50
Testing effectiveness (Phase 2)Study completedNCT00005804
What this trial is testing

Bone Marrow Transplantation in Treating Patients With Hematologic Cancer

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+4 more
Fred Hutchinson Cancer Center
Early research (Phase 1)Ended earlyNCT01207076
What this trial is testing

AHN-12 Biodistribution in Advanced Leukemia

Who this might be right for
Acute Myelogenous LeukemiaMyelodysplastic SyndromeAcute Lymphoblastic Leukemia+1 more
Masonic Cancer Center, University of Minnesota 8
Large-scale testing (Phase 3)Study completedNCT01188798
What this trial is testing

Methotrexate or Pentostatin for Graft-versus-host Disease Prophylaxis in Risk-adapted Allogeneic Bone Marrow Transplantation for Hematologic Malignancies

Who this might be right for
Acute Lymphoblastic LeukemiaAcute Myelocytic LeukemiaChronic Myelocytic Leukemia+2 more
St. Jude Children's Research Hospital 6
Large-scale testing (Phase 3)UnknownNCT00002771
What this trial is testing

Chemotherapy, Interferon, and Bone Marrow Transplantation in Treating Patients With Chronic Myelogenous Leukemia

Who this might be right for
Leukemia
German CML Study Group 750
Testing effectiveness (Phase 2)Study completedNCT00526292
What this trial is testing

Chemotherapy and a Donor Natural Killer Cell Infusion in Treating Patients With Relapsed or Persistent Leukemia or Myelodysplastic Syndrome After a Donor Stem Cell Transplant

Who this might be right for
LeukemiaMyelodysplastic Syndromes
Memorial Sloan Kettering Cancer Center 12
Not applicableStudy completedNCT00186342
What this trial is testing

Sibling and Unrelated Donor Hematopoietic Cell Transplant in Hematologic Malignancies

Who this might be right for
Acute DiseaseMyelodysplastic SyndromesLeukemia, Myeloid, Chronic+4 more
Stanford University 120
Large-scale testing (Phase 3)Study completedNCT02103322
What this trial is testing

Comparative Bioequivalence Study in Adult Patients Suffering From Chronic Myeloid Leukemia & Gastrointestinal Stromal Tumor Under Fed Conditions

Who this might be right for
Chronic Myeloid LeukemiaGastrointestinal Stromal Tumor
Amneal Pharmaceuticals, LLC 48
Testing effectiveness (Phase 2)Looking for participantsNCT02727803
What this trial is testing

Personalized NK Cell Therapy in CBT

Who this might be right for
Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 PositiveAcute Biphenotypic LeukemiaAcute Lymphoblastic Leukemia+23 more
M.D. Anderson Cancer Center 100
Early research (Phase 1)Looking for participantsNCT06904066
What this trial is testing

Autologous T Cells Transduced With Retroviral Vectors Expressing TCRs for Participant-specific Neoantigens in Patients With Hematologic Malignancies

Who this might be right for
Malignancy, HematologicNeoplasms, HematologicNeoplasms, Hematopoietic+8 more
National Cancer Institute (NCI) 86
Not applicableNot Yet RecruitingNCT07146542
What this trial is testing

Expression Pattern and Possible Clinical Significance of CD81 In Myeloid Leukemia

Who this might be right for
Acute Myeloid LeukemiaChronic Myeloid Leukemia
Assiut University 66
Testing effectiveness (Phase 2)Study completedNCT00003572
What this trial is testing

Total-Body Irradiation, Tacrolimus, and Mycophenolate Mofetil Plus Bone Marrow Transplantation in Treating Patients With Hematologic Cancers

Who this might be right for
LeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm+1 more
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 20
Not applicableStudy completedNCT00053157
What this trial is testing

Sargramostim in Reducing Graft-Versus-Host Disease in Patients Who Are Undergoing Donor Stem Cell Transplantation for Hematologic Cancer or Aplastic Anemia

Who this might be right for
Chronic Myeloproliferative DisordersGraft Versus Host DiseaseLeukemia+3 more
Roswell Park Cancer Institute 10
Not applicableStudy completedNCT04605211
What this trial is testing

A Distress Reduction Intervention for Patients With BCR-ABL-Negative MPNs or CML on Tyrosine Kinase Inhibitors

Who this might be right for
Myeloproliferative NeoplasmChronic Phase Chronic Myelogenous LeukemiaChronic Myeloid Leukemia
University of California, San Francisco 47
Large-scale testing (Phase 3)Study completedNCT00123487
What this trial is testing

Advanced Chronic Myelogenous Leukemia (CML) - Follow On: Study of BMS-354825 in Subjects With CML

Who this might be right for
Myeloid Leukemia, Chronic, Accelerated PhaseLeukemia, Lymphoblastic, Acute, Philadelphia-Positive
Bristol-Myers Squibb 638
Next Page